Rare case of Self-evisceration as initial presentation of schizoaffective disorder: A report

Written By :  Dr. Shivi Kataria
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-09-03 14:30 GMT   |   Update On 2023-09-04 06:47 GMT

schizoaffective disorder is typically diagnosed in adolescence and young adulthood characterized by major mood episodes and symptoms of schizophrenia that include disorganized speech, delusions, paranoia, and hallucinations. A rare case, published by Hamlin et al in Hindawi Journal reports a 39-year-old male patient with undiagnosed schizoaffective disorder who self-eviscerated his intestines during an episode of psychosis.

Schizoaffective disorder is associated with risk factors, including a history of abuse and cannabis use. In the present case report, a 39-year-old male was found crawling in a parking lot with several feet of intestines dragging on the ground. He received an emergent exploratory laparotomy with a partial colectomy. After being stabilized medically, he was transferred to the inpatient psychiatry unit. A urine drug screen was positive only for cannabis.

On conducting a Mental Status Examination, the patient was fully oriented and able to recall stabbing himself in the abdomen because characters in his mind told him to, having an out-of-body experience as he watched himself pull out several feet of intestines.

He felt compelled to follow the voices’ commands because he had guilt about his history of sexual abuse towards women. He endorsed paranoia and auditory hallucinations for the last 10 years but never sought treatment. He had no suicidal ideation and expressed a fear of hurting himself upon returning home if the voices persisted. He recalled periods in his life when he had little need for sleep, had racing thoughts, and felt that signs and advertisements were speaking directly to him. His social history was notable for heavy cannabis use beginning at age 18. He was a daily user for 5-6 years and began experiencing paranoia and auditory hallucinations.

Despite quitting for two years, the psychotic symptoms persisted, and he reported currently using cannabis 3-4 days per week. He also had a history of trauma and was emotionally and physically abused by his father who had alcohol use disorder.

Given this patient’s history of mood fluctuation and psychosis for years, even in the absence of cannabis use, he was diagnosed with schizoaffective disorder, bipolar type. He responded to olanzapine 10 mg twice daily and valproic acid 500 mg three times daily, and was discharged after two weeks of hospitalization.

This is the third report of self-evisceration of the intestines as the initial presentation of a schizophrenia spectrum disorder in a nonsuicidal patient while there are numerous other reported cases with same presentation as suicide attempts in patients with psychiatric illness.

This case serves to emphasize the importance of risk factor identification and intervention in patients with suspected psychosis to avoid significant morbidity and disease burden on the health-care system. It has been found that, the incidence of childhood physical and emotional trauma increase the risk of psychiatric disorders between 38% and 50% of patients. Studies have also demonstrated that daily use of marijuana increases the risk up to five times. It has also been found that chronic marijuana users who have a specific variant of the AKT1 gene and catechol-O-methyltransferase (COMT) gene are at an increased risk of developing psychosis.

“If specific gene variations or biomarkers can be defined and have predictive value, screening tests could be developed to allow physicians to provide better risk stratification to this subgroup of patients, which may help reduce morbidity, mortality, and disease burden on the healthcare system”, write authors in discussion.

Source: Case Reports in Psychiatry: Hindawi

https://doi.org/10.1155/2023/4334552

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News